about
Interference with the Autophagic Process as a Viral Strategy to Escape from the Immune Control: Lesson from Gamma HerpesvirusesTargeting of prosurvival pathways as therapeutic approaches against primary effusion lymphomas: past, present, and FuturePrimary effusion lymphoma cell death induced by bortezomib and AG 490 activates dendritic cells through CD91JNK and macroautophagy activation by bortezomib has a pro-survival effect in primary effusion lymphoma cells.Targeting COX-2/PGE(2) pathway in HIPK2 knockdown cancer cells: impact on dendritic cell maturation.The activation of KSHV lytic cycle blocks autophagy in PEL cells.HSP70 inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D release and immunogenic cell death in primary effusion lymphoma.Kaposi sarcoma associated herpesvirus (KSHV) induces AKT hyperphosphorylation, bortezomib-resistance and GLUT-1 plasma membrane exposure in THP-1 monocytic cell line.Epstein-barr virus blocks the autophagic flux and appropriates the autophagic machinery to enhance viral replication.STAT3 activation by KSHV correlates with IL-10, IL-6 and IL-23 release and an autophagic block in dendritic cells.KSHV ORF67 encoded lytic protein localizes on the nuclear membrane and alters emerin distribution.The BFRF1 gene of Epstein-Barr virus encodes a novel protein.Identification and characterization of the product encoded by ORF69 of Kaposi's sarcoma-associated herpesvirusDeletion of Epstein-Barr virus BFLF2 leads to impaired viral DNA packaging and primary egress as well as to the production of defective viral particlesRegulation of the expression of the Epstein-Barr virus early gene BFRF1.Characterization and intracellular localization of the Epstein-Barr virus protein BFLF2: interactions with BFRF1 and with the nuclear lamina.BFRF1 of Epstein-Barr virus is essential for efficient primary viral envelopment and egress.KSHV reduces autophagy in THP-1 cells and in differentiating monocytes by decreasing CAST/calpastatin and ATG5 expression.Concomitant reduction of c-Myc expression and PI3K/AKT/mTOR signaling by quercetin induces a strong cytotoxic effect against Burkitt's Lymphoma.Intracellular localization of the Epstein-Barr virus BFRF1 gene product in lymphoid cell lines and oral hairy leukoplakia lesions.Transcription of latent and replicative Epstein-Barr-virus genes in bone-marrow and peripheral-blood mononuclear cells of healthy donors.Activation of dendritic cells by tumor cell death.PKC theta and p38 MAPK activate the EBV lytic cycle through autophagy induction.HHV-8 reduces dendritic cell migration through down-regulation of cell-surface CCR6 and CCR7 and cytoskeleton reorganization.Plasmid functions involved in the stable propagation of the pKD1 circular plasmid in Kluyveromyces lactis.Prevalence of infection by HHV-8, HIV, HCV and HBV among pregnant women in Burkina Faso.Susceptibility to human herpesvirus-8 infection in a healthy population from Sardinia is not directly correlated with the expression of HLA-DR alleles.High rate of human herpesvirus-8 seroprevalence in thalassemic patients in Italy.Environmental Factors Influence the Rate of Human Herpesvirus Type 8 Infection in a Population with High Incidence of Classic Kaposi SarcomaDirect correlation between human herpesvirus-8 seroprevalence and classic Kaposi's sarcoma incidence in Northern SardiniaLack of Serologic Association Between Human Herpesvirus-8 Infection and Multiple Myeloma and Monoclonal Gammopathies of Undetermined SignificanceKaposi's Sarcoma–Associated Herpesvirus/Human Herpesvirus 8 Is Not Detectable in Peripheral Blood Mononuclear Cells of the Relatives of Sporadic KS PatientsThe SV40 T-antigen induces premature apoptotic mammary gland involution during late pregnancy in transgenic mice
P50
Q28080898-3DF83491-909D-40AB-9BAB-A6E16B705EC7Q28081199-29D9F7B4-14B8-4A6F-A2D2-CB6703A0A6AAQ28481417-C027F261-5C2B-4EC6-8B85-1813A9B50DA0Q35006105-23C311C5-B92C-4F3F-B42B-973ECC3B9EB4Q36380799-C5B8D4BB-7904-449E-BB0D-B4D6F0691158Q36777265-9FDA972B-798C-4E34-973C-A68B624B936EQ37062084-960ECDFE-0AE1-482E-8EA1-84005367A653Q37418380-E1CFFE24-63B8-44D6-AAB2-47AF1EE3960BQ38964209-64E5661D-61B8-44F5-BDFB-FC6233472AB7Q39020179-DAA02A30-2189-4A5B-AB79-7AE9DFCD4E75Q39159499-9F040B9B-9DBC-471F-B068-7E0C4BC3F9D4Q39590218-CB6BA4F1-02A4-4B06-B7C3-9EDE137CF736Q40008314-514FA9CC-DA1A-45E7-B5D3-5898EEA44919Q40011084-603CB88E-ABEA-4519-80FB-F5EBA9484FDBQ40331535-76ABDAEE-705A-402E-B0BC-F5396C270DCAQ40454370-2974614E-8045-4FEB-A1B9-88E89B0AD967Q40454379-25E39AC4-11CF-4915-94B9-69064619497DQ40509197-256F72EF-E599-4E84-8354-0CA18CF7DA18Q40543100-2BE3C917-28C7-4693-96CB-2A65F813610BQ40613857-5B68F427-8684-4AEC-BC8E-8126E6BEB153Q41121317-36AD4449-65D8-4104-9B85-17D4D815A64EQ41274453-3FB7FDEF-BE26-4EED-84D7-CE93D74C10EAQ41366330-E25997C6-9AA9-42C1-A089-AE722D93ADA7Q42325519-A8E1E8DE-F801-4E49-B3AE-795E05C06157Q42622620-FE996950-A7B0-4A4B-87D3-D708E0E7D802Q42986663-AA05B3EA-815E-4E80-8E45-C04CE4EDEE4AQ43838560-9E25139A-DCB7-4D36-A3FF-843CFE20973AQ47795261-6C61C6D5-DB16-4DE7-A373-D7F21500B6A0Q56839109-C7BD094C-FD2B-4334-B6E9-E631E7BFC34CQ56839111-C9D6140E-913A-4566-862D-80E1E37B35DEQ56839112-ED7B948E-334B-48D3-91CC-9FD769814289Q56839114-76D5A205-5E81-41C1-BBFE-2ADA74D17DBDQ56839115-D5927138-BAFD-44E6-B9B3-CFC9AE4B700B
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Roberta Santarelli
@ast
Roberta Santarelli
@en
Roberta Santarelli
@es
Roberta Santarelli
@nl
Roberta Santarelli
@sl
type
label
Roberta Santarelli
@ast
Roberta Santarelli
@en
Roberta Santarelli
@es
Roberta Santarelli
@nl
Roberta Santarelli
@sl
prefLabel
Roberta Santarelli
@ast
Roberta Santarelli
@en
Roberta Santarelli
@es
Roberta Santarelli
@nl
Roberta Santarelli
@sl
P106
P1153
7003648319
P21
P31
P496
0000-0002-9416-7594